Physician profile
Peter Arnold
NPI 1598979064
$206,214.90
in general payments reported to CMS, 2019-2025
21 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $42K · 2021: $14K · 2022: $18K · 2023: $26K · 2024: $30K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $48K · Travel and Lodging: $22K · Food and Beverage: $2,639 · Long Term Medical Supply Or Device Loan: $1,027 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,092.50 |
| Travel and Lodging | $22,499.04 |
| Food and Beverage | $2,639.10 |
| Long Term Medical Supply Or Device Loan | $1,026.78 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $198,018.01 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tela Bio, INC. | $3,884.90 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Kerecis Limited | $877.16 | 2019-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Access Pro Medical, LLC | $558.42 | 2022-2025 | Matriderm, Matriderm |
| Depuy Synthes Sales INC. | $504.69 | 2019-2022 | |
| Stryker Corporation | $413.39 | 2021-2025 | Na, Delta, Smartlock |
| Tei Biosciences INC | $326.20 | 2019 | |
| Mentor Worldwide LLC | $295.16 | 2019 | |
| Axogen | $255.65 | 2019 | |
| Sientra, INC. | $167.96 | 2021 | |
| Davol INC. | $150.35 | 2025 | Phasix Mesh |
| Allergan, INC. | $140.26 | 2019-2021 | |
| Baxter Healthcare | $137.36 | 2019 | |
| Kls-Martin L.P. | $119.81 | 2019 | |
| Somavac Medical Solutions, INC. | $113.16 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $70.60 | 2022 | |
| Smith+Nephew, INC. | $54.55 | 2019 | |
| Acera Surgical, INC. | $52.99 | 2019 | |
| Zimmer Biomet Holdings, INC. | $36.80 | 2019 | |
| Medline Industries LP | $21.36 | 2023 | |
| Kci USA, INC. | $16.12 | 2023 | Abthera Advance, Prevena, V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.